Listed

Maximus, Inc.: Form 10-Q for the period ended Mar 31, 2023

Filed with the SEC on May 4, 2023 and accepted by EDGAR at May 4, 2023, 16:08 ET.

Share

Management's discussion and analysis

As filed, 34,988 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion is intended to help the reader understand our business, financial condition, results of operations, liquidity and capital resources. You should read this discussion in conjunction with our financial statements and related notes in Item 1 and in the 'Special Note Regarding Forward-Looking Statements' in this Quarterly Report on Form 10-Q and the audited financial statements and related notes, risk factors and Management's Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for fiscal year 2022 filed with the Securities and Exchange Commission on November 22, 2022.

Business Overview

We are a global company with approximately 39,500 employees and 12,550 contingent workers dedicated to helping governments on four continents to administer their citizen-facing programs. Under our mission of Moving People Forward, we offer industry-leading expertise, including citizen engagement, eligibility and program integrity, independent clinical assessments and case management, and technology modernization services to enable citizens around the globe to successfully engage with their governments at all levels. We are instrumental in helping people who need governmental support get it.

Over the past five years, we have executed a three-pronged growth strategy: we have evolved through our digital transformation to meet the modernization needs of our clients; we have expanded our clinical assessment capabilities to meet growing demand for independent and conflict-free clinical services; and we have expanded our markets, both organically and through acquisitions.

In fiscal year 2022, we refreshed our strategy and updated the three pillars on which we will focus growth efforts for the next three to five years:

  • Customer Services, Digitally Enabled. We apply proven technologies, data, and best practices to make government programs more customer-focused, effective, and deserving of the public's trust. We make it easier for people to connect to government services based on their individual preferences and abilities. We are elevating the customer experience to achieve higher levels of satisfaction, performance, and outcomes through intelligent automation and cognitive computing.
  • Future of Health. We are expanding our clinical-related services and are experienced in delivering clinical BPS services at scale. We have established an extensive set of services that frequently requires a network of healthcare professionals who can complete clinical assessments, provide occupational health and independent medical review services, and adjudicate complicated benefits appeals. With the formation of Maximus Public Health ("MPH"), we are able to serve as a resource to governments as they respond to public health threats and address lessons learned from the global pandemic.
  • Advanced Technologies for Modernization. We are furthering our credibility as a technology leader, enabling the transformation of government programs to be resilient, dynamic, integrated, and equitable. Leveraging our deep relationships and program knowledge, we are delivering technology-driven business transformation of government missions with a strategic near-term focus on hybrid cloud solutions, information intelligence, and hyper-automation.

Financial Overview

A number of factors have affected our results for the second quarter of fiscal year 2023, the most significant of which we have listed below. More detail on these changes is presented below within our "Results of Operations" section.

  • Our business has grown, with new and expanded work replacing short-term COVID-19 work in prior years.
  • Our SG&A cost base has expanded with the growth of the business, including investments in our workforce and business infrastructure.
  • Our international business results have been tempered by the strength of the U.S. Dollar against the other currencies in which we operate.
  • The cost of financing our debt has increased year-over-year as interest rates have increased.

Results of Operations

The following table sets forth items from our consolidated statements of operations for the three months and six months ended March 31, 2023 and March 31, 2022.

(dollars in thousands, except per share data)

Table MD&A 1: Consolidated Results of Operations For the Three Months Ended March 31, 2023 March 31, 2022 For the Six Months Ended March 31, 2023 March 31, 2022
Revenue $1,206,852 $1,177,326 $2,456,098 $2,328,202
Cost of revenue 978,249 948,875 1,982,748 1,871,596
Gross profit 228,603 228,451 473,350 456,606
Gross profit percentage 18.9% 19.4% 19.3% 19.6%
Selling, general, and administrative expenses 142,448 130,307 288,900 254,528
Selling, general, and administrative expenses as a percentage of revenue 11.8% 11.1% 11.8% 10.9%
Amortization of intangible assets 23,650 22,856 47,168 45,261
Operating income 62,505 75,288 137,282 156,817
Operating margin 5.2% 6.4% 5.6% 6.7%
Interest expense 20,999 9,438 42,605 19,076
Other income, net 818 715 1,084 404
Income before income taxes 42,324 66,565 95,761 138,145
Provision for income taxes 10,536 16,469 23,978 34,719
Effective tax rate 24.9% 24.7% 25.0% 25.1%
Net income $31,788 $50,096 $71,783 $103,426
Earnings per share:
Basic $0.52 $0.81 $1.17 $1.66
Diluted $0.52 $0.80 $1.17 $1.66

Our business segments have different factors driving revenue fluctuations and profitability. The sections that follow cover these segments in greater detail. Our revenue reflects fees earned for services provided. Cost of revenue consists of direct costs related to labor and related overhead, subcontractor labor, outside vendors, rent, and other direct costs. The largest component of cost of revenue, approximately two-thirds, is labor, including subcontracted labor.

Table MD&A 2: Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended March 31, 2023

(dollars in thousands)

Revenue Dollars % Change Cost of Revenue Dollars % Change Gross Profit Dollars % Change
Three Months Ended March 31, 2022 $1,177,326 $948,875 $228,451
Organic effect 46,020 3.9% 44,646 4.7% 1,374 0.6%
Disposal of businesses (3,456) (0.3)% (3,343) (0.4)% (113) —%
Acquired growth 1,335 0.1% 687 0.1% 648 0.3%
Currency effect compared to the prior period (14,373) (1.2)% (12,616) (1.3)% (1,757) (0.8)%
Three Months Ended March 31, 2023 $1,206,852 2.5% $978,249 3.1% $228,603 0.1%

Table MD&A 3: Changes in Revenue, Cost of Revenue, and Gross Profit for the Six Months Ended March 31, 2023

(dollars in thousands)

Revenue Dollars % Change Cost of Revenue Dollars % Change Gross Profit Dollars % Change
Six Months Ended March 31, 2022 $2,328,202 $1,871,596 $456,606
Organic effect 164,664 7.1% 143,569 7.7% 21,095 4.6%
Disposal of businesses (3,456) (0.1)% (3,343) (0.2)% (113) —%
Acquired growth 3,448 0.1% 1,943 0.1% 1,505 0.3%
Currency effect compared to the prior period (36,760) (1.6)% (31,017) (1.7)% (5,743) (1.3)%
Six Months Ended March 31, 2023 $2,456,098 5.5% $1,982,748 5.9% $473,350 3.7%

Selling, general, and administrative expenses ("SG&A")

Selling, general, and administrative expenses ("SG&A") consist of indirect costs related to general management, marketing, and administration. It is primarily composed of labor costs. These costs may be incurred at a segment level, for dedicated resources that are not client-facing, or at a corporate level. Corporate costs are allocated to segments on a consistent and rational basis. Fluctuations in our SG&A are primarily driven by changes in our administrative cost base, which is not directly driven by changes in our revenue. As part of our work for the U.S. federal government and many states, we allocate these costs using a methodology driven by the U.S. Federal Cost Accounting Standards.

Our SG&A expense has increased with growth in our business and investments made in our workforce and infrastructure. Our SG&A expense also includes losses relating to the sale of two small businesses in 2023.

Interest Expense

Interest expense for the three months ended March 31, 2022 and March 31, 2023, increased from $9.4 million to $21.0 million. Interest expense for the six months ended March 31, 2022 and March 31, 2023 increased from $19.1 million to $42.6 million. These increases are principally due to market rate increases.

Our effective interest rate was 5.9% at March 31, 2023, compared to 2.4% at March 31, 2022. We have mitigated our risk by fixing interest rates on $650 million of our debt and our near term capital allocation plan continues to prioritize reducing our debt using our free cash flow. At our current debt balances, a 100 basis point change in SOFR would result in an increased annual interest expense of $6.4 million.

Provision for Income Taxes

Our effective income tax rate for the three and six months ended March 31, 2023, was 24.9% and 25.0%, respectively, compared to 24.7% and 25.1% for the three and six months ended March 31, 2022. For fiscal year 2023, we expect the effective tax rate to be between 24.5% and 25.5%.

U.S. Federal Services Segment

Our U.S. Federal Services Segment delivers end-to-end solutions that help various U.S. federal government agencies better deliver on their mission, including program operations and management, clinical services, and technology solutions. This also includes appeals and assessments services, system and application development, IT modernization, and maintenance services. The segment also contains certain state-based assessments and appeals work that is part of the segment's heritage which continues to be managed within this segment. Benefiting from the 2021 acquisition of the Attain Federal business, now managed as Technology Consulting Services, the segment executes on its digital strategy to deliver technology solutions that advance agency missions, including the challenge to modernize, provide better customer experience, and drive process efficiencies. The segment continues to expand its clinical solutions with the acquisition of VES Group, Inc., which manages the clinical evaluation process for U.S. veterans and service members on behalf of the U.S. Department of Veterans Affairs.

Table MD&A 4: U.S. Federal Services Segment - Financial Results

(dollars in thousands)

For the Three Months Ended March 31, 2023 March 31, 2022 For the Six Months Ended March 31, 2023 March 31, 2022
Revenue $584,075 $573,288 $1,202,242 $1,155,159
Cost of revenue 461,201 458,135 956,674 913,430
Gross profit 122,874 115,153 245,568 241,729
Selling, general, and administrative expenses 75,050 68,949 146,699 133,874
Operating income 47,824 46,204 98,869 107,855
Gross profit percentage 21.0 % 20.1 % 20.4 % 20.9 %
Operating margin percentage 8.2 % 8.1 % 8.2 % 9.3 %

Our revenue and cost of revenue for the three months ended March 31, 2023, increased 1.9% and 0.7%, respectively. For the six months ended March 31, 2023, growth was 4.1% and 4.7%, respectively. All growth in fiscal year 2023 was organic.

Our U.S. Federal Services business grew primarily from volume growth in our VES business. Profit margins were tempered as the business is being scaled up for higher volumes, which we anticipate in future quarters. The three months ended March 31, 2023 received a short-term margin benefit from a contract close-out. Our fiscal year 2022 results included the closing stages of short-term, pandemic related services, which operated at higher margins.

We anticipate that our U.S. Federal Services business will continue to grow in fiscal year 2023, driven primarily by additional volumes anticipated in the VES business. We anticipate full year operating margins will range between 10% and 11%.

U.S. Services Segment

Our U.S. Services Segment provides a variety of business process services ("BPS"), such as program administration, assessments, and related consulting work for U.S. state and local government programs. These services support a variety of programs, including the Affordable Care Act ("ACA"), Medicaid, the Children's Health Insurance Program ("CHIP"), Temporary Assistance to Needy Families ("TANF"), and child support programs. As part of the government's COVID-19 response efforts, the segment supported contact tracing, disease investigation, and vaccine distribution support services during the peak of the pandemic. The segment also successfully expanded into the unemployment insurance market where longer term opportunities have materialized. As part of the broader strategy to evolve clinically and address societal macro trends such as aging populations and rising costs, the segment continues to expand its offerings in public health with new work in in-person assessments.

Table MD&A 5: U.S. Services Segment - Financial Results

(dollars in thousands)

For the Three Months Ended March 31, 2023 March 31, 2022 For the Six Months Ended March 31, 2023 March 31, 2022
Revenue $449,703 $398,077 $889,181 $784,494
Cost of revenue 363,687 313,106 719,567 609,824
Gross profit 86,016 84,971 169,614 174,670
Selling, general, and administrative expenses 43,415 38,273 89,257 73,375
Operating income 42,601 46,698 80,357 101,295
Gross profit percentage 19.1 % 21.3 % 19.1 % 22.3 %
Operating margin percentage 9.5 % 11.7 % 9.0 % 12.9 %

Our revenue and cost of revenue for the three months ended March 31, 2023, increased 13.0% and 16.2%, respectively, compared to the three months ended March 31, 2022. For the six months ended March 31, 2023, our revenue and cost of revenue increased 13.3% and 18.0%, respectively, compared to the six months ended March 31, 2022. All movement was organic and net of anticipated declines in short-term work related to the pandemic.

Revenue has increased from expanded contracts and new work, but margins remain tempered as the short-term, pandemic-related work from prior years has declined.

This segment is expected to see the greater benefit from the resumption of Medicaid eligibility redeterminations. The nature and timing of the benefit will be dependent upon how the states coordinate the return of these services, but we continue to anticipate that services will commence during our third fiscal quarter, with a greater contribution in the final quarter of the year. We anticipate a full year operating profit margin will be between 9% and 11%.

Outside the U.S. Segment

Our Outside the U.S. Segment provides BPS for international governments and commercial clients, transforming the lives of people around the world. Helping people find employment, access vital support, and remain healthy, these services include health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker related services. We support programs and deliver services in the U.K., including the Health Assessment Advisory Service ("HAAS") and Restart; Australia, including Workforce Australia (formerly jobactive) and the Disability Employment Service; Canada, including the Employment Program of British Columbia; in addition to Italy, Saudi Arabia, Singapore, South Korea, and UAE, where we predominantly provide employment support and job seeker services.

Table MD&A 6: Outside the U.S. Segment - Financial Results

(dollars in thousands)

For the Three Months Ended March 31, 2023 March 31, 2022 For the Six Months Ended March 31, 2023 March 31, 2022
Revenue $173,074 $205,961 $364,675 $388,549
Cost of revenue 153,361 177,634 306,507 348,342
Gross profit 19,713 28,327 58,168 40,207
Selling, general, and administrative expenses 23,425 24,011 51,814 45,351
Operating income/(loss) (3,712) 4,316 6,354 (5,144)
Gross profit percentage 11.4 % 13.8 % 16.0 % 10.3 %
Operating margin percentage (2.1) % 2.1 % 1.7 % (1.3) %

23

Table MD&A 7: Outside the U.S. Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended March 31, 2023

(dollars in thousands)

Revenue Amount % Change Cost of Revenue Amount % Change Gross Profit Amount % Change
Three Months Ended March 31, 2022 $205,961 $177,634 $28,327
Organic effect (16,393) (8.0)% (9,001) (5.1)% (7,392) (26.1)%
Disposal of businesses (3,456) (1.7)% (3,343) (1.9)% (113) (0.4)%
Acquired growth 1,335 0.6% 687 0.4% 648 2.3%
Currency effect compared to the prior period (14,373) (7.0)% (12,616) (7.1)% (1,757) (6.2)%
Three Months Ended March 31, 2023 $173,074 (16.0)% $153,361 (13.7)% $19,713 (30.4)%

Table MD&A 8: Outside the U.S. Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Six Months Ended March 31, 2023

(dollars in thousands)

Revenue Amount % Change Cost of Revenue Amount % Change Gross Profit Amount % Change
Six Months Ended March 31, 2022 $388,549 $348,342 $40,207
Organic effect 12,894 3.3% (9,418) (2.7)% 22,312 55.5%
Disposal of businesses (3,456) (0.9)% (3,343) (1.0)% (113) (0.3)%
Acquired growth 3,448 0.9% 1,943 0.6% 1,505 3.7%
Currency effect compared to the prior period (36,760) (9.5)% (31,017) (8.9)% (5,743) (14.3)%
Six Months Ended March 31, 2023 $364,675 (6.1)% $306,507 (12.0)% $58,168 44.7%

Our results for the three months ended March 31, 2023, were impacted by declines in our Australian contract. Following rebid activity in June 2022, these contracts were significantly reduced in scope.

Our results for the six months ended March 31, 2023, were affected by the decline in Australian business, but this was offset by significant profitable growth in our expanding Restart program, which ramped up through the first quarter of this fiscal year.

This segment also had revenue and margins tempered by delays in a major new program, as well as challenges in achieving volumes in some of our employment programs as a result of low unemployment in our emerging markets.

In March 2023, we sold a small commercial practice in the United Kingdom and our employment operations in Sweden. Prospectively, we anticipate this will marginally improve our profit margins.

Much of our revenue growth stems from our employment services contracts, where we are paid based upon our ability to place individuals in long-term sustained employment. As a result, changes in our estimates of our ability to place people in work and the time that this will take can have significant effects on our revenue. Our estimates are based upon historical performance, where appropriate and available, and are constantly updated.

We anticipate operating margins will range between 1% and 3% for the full fiscal year.

Liquidity and Capital Resources

Our primary sources of liquidity are cash on hand, cash from operations, and availability under our revolving credit facilities. As of March 31, 2023, we had $56.3 million in cash and cash equivalents. We believe that our current cash position, access to our revolving debt, and cash flow generated from operations should be not only sufficient for our operating requirements but also to enable us to fund required long-term debt repayments, dividends and any share purchases we might choose to make. See "Note 6. Debt and Derivatives" to the Consolidated Financial Statements for a more detailed discussion of our debt financing arrangements.

During the first half of fiscal year 2023, we entered into a number of debt-related transactions.

  • We entered into additional interest rate swaps, to bring the total balance of our credit facility subject to fixed rates to $650 million. This allows us greater opportunity to predict and manage our interest payments.
  • We amended both our debt and the corresponding interest rate swaps to use interest rates based upon the Secured Overnight Financing Rate (SOFR), replacing the previous LIBOR basis. This transaction anticipates the phasing out of LIBOR rates in 2023.
  • As part of the transition to SOFR, we took the opportunity to redeem some of our Term Loan B debt.

Table MD&A 9: Net Change in Cash and Cash Equivalents and Restricted Cash

(in thousands)

Operating activities: For the Six Months Ended March 31, 2023 March 31, 2022
Net cash provided by operating activities $175,037 $111,859
Net cash used in investing activities (24,627) (22,902)
Net cash used in financing activities (171,671) (133,883)
Effect of foreign exchange rates on cash and cash equivalents and restricted cash 3,186 324
Net change in cash and cash equivalents and restricted cash $(18,075) $(44,602)

Net Cash Provided By Operating Activities

Net cash provided by operating activities was $175.0 million in the first half of fiscal year 2023, an increase of $63.2 million. This increase was principally from our improved cash collections; our Days Sales Outstanding ("DSO") at September 30, 2022 was 62 days; the corresponding DSO at March 31, 2023 was 56 days. This DSO is below our anticipated range and will likely return to a balance between 60-70 days by year end. Increased interest payments on our debt, driven by interest rate increases, were offset by declines in income tax payments.

Net Cash Used In Investing Activities

Investing cash outflows in fiscal years 2023 and 2022 reflect acquisitions of property and equipment and investment in software. In fiscal year 2023, we received payments for the sale of our Swedish business and an installment payment on the sale of a small commercial practice in the United Kingdom.

Net Cash Used In Financing Activities

Net financing cash outflows reflect mandatory and early payments on our debt.

At September 30, 2022, our restricted cash balance was inflated by a large customer receivable of $60.7 million, which was paid to us after we had sold the balance to a third party, resulting in a financing cash inflow. During the period ended March 31, 2023, the payment was made and no similar timing differences existed as of March 31, 2023, resulting in a net cash outflow.

Credit Facilities

Our principal debt agreement is with JPMorgan Chase Bank N.A. (the Credit Agreement). At March 31, 2023, we owed $1.29 billion under the Credit Agreement, with access to an additional $600 million through a revolving credit facility. Mandatory repayments are required under this agreement through May 2028, when the agreement ends, and must be renegotiated or the funds repaid.

The Credit Agreement contains a number of covenants with which we are expected to comply. Failure to meet these requirements would result in a need to renegotiate the agreement or a requirement to repay our outstanding debt in full. There are two financial covenants, both defined in the Credit Agreement.

  • Our Consolidated Net Total Leverage Ratio means, for any twelve-month period, the ratio of our Funded Debt, offset by up to $75 million of unrestricted cash (Consolidated Total Leverage), against our Consolidated EBITDA (as defined by the Credit Agreement). To comply with our Credit Agreement, this ratio cannot exceed 4.00:1.00 at the end of each quarter, with a step-up to 4.50:1.00 under certain circumstances. This ratio also determines both our interest rate and the charge we pay on the unused component of our revolving credit facility, with the charge increasing as the leverage ratio increases.
  • Our Consolidated Net Interest Coverage Ratio means, for any twelve-month period, the ratio of our Consolidated EBITDA against our Consolidated Net Interest Expense, as defined by the Credit Agreement. To comply with our Credit Agreement, this ratio cannot be less than 3.00:1.00 at the end of each quarter.

Consolidated EBITDA also drives certain permissions within the Credit Agreement, such as the level of investment we are entitled to make without seeking additional approval from our lenders.

Our Credit Agreement defines Consolidated EBITDA, as well as other components of the calculations above. The definition of Consolidated EBITDA requires us to include adjustments not typically included within EBITDA, including unusual, non-recurring expenses, certain non-cash adjustments, the pro forma effects of acquisitions and disposals and estimated synergies from acquisitions. As a result, Consolidated EBITDA as defined by the Credit Agreement may not be comparable to EBITDA or related or similarly-titled measures presented by other companies.

We have summarized below the components of our two financial ratio calculations, including the components of Consolidated EBITDA as defined by the Credit Agreement which are included within our financial statements. At March 31, 2023, we were in compliance with all applicable covenants of our Credit Agreement. We do not believe that these covenants represent a significant restriction in our ability to operate our business or to pay our dividends.

Table MD&A 10: Reconciliation of Net Income to Consolidated EBITDA as defined by our Credit Agreement

(in thousands)

For the Three Months Ended March 31, 2023 For the Trailing Twelve Months Ended March 31, 2023
Net income $31,788 $172,185
Adjustments:
Interest expense 20,999 69,494
Other (income)/expense, net (818) 2,155
Provision for income taxes 10,536 62,529
Amortization of intangibles 23,650 92,372
Stock compensation expense 9,540 29,367
Acquisition-related expenses (126) (635)
Gain on sale of land and building — (11,046)
Loss on sale of businesses 883 883
Depreciation and amortization of property, equipment, and capitalized software 14,041 47,452
Pro forma and other adjustments permitted by our credit agreement (1,481) 37,016
Consolidated EBITDA (as defined by our Credit Agreement) $109,012 $501,772

26

(in thousands, except ratio data)

Table MD&A 11: Consolidated Net Total Leverage Ratio For the Trailing Twelve Months Ended March 31, 2023
Funded Debt (as defined by our Credit Agreement) $1,298,256
Cash and cash equivalents up to $75 million 56,344
Consolidated Net Total Leverage (as defined by our Credit Agreement) $1,241,912
Consolidated Net Total Leverage Ratio (as defined by our Credit Agreement) 2.48

(in thousands, except ratio data)

Table MD&A 12: Consolidated Net Interest Coverage Ratio For the Trailing Twelve Months Ended March 31, 2023
Consolidated EBITDA (as defined by our Credit Agreement) $501,772
Interest expense 69,494
Components of other income/expense, net allowed in ratio calculation (1,084)
Consolidated Net Interest Expense (as defined by our Credit Agreement) $68,410
Consolidated Net Interest Coverage Ratio (as defined by our Credit Agreement) 7.33

Cash in Foreign Locations

We have no requirement to remit funds from our foreign locations to the United States. We will continue to explore opportunities to remit additional funds, taking into consideration the working capital requirements and relevant tax rules in each jurisdiction. When we are unable to remit funds back without incurring a penalty, we will consider these funds indefinitely reinvested until such time as these restrictions are changed. As a result, we do not record U.S. deferred income taxes on any funds held in foreign jurisdictions. We have not attempted to calculate our potential liability from any transfer of these funds, as any such transaction might include tax planning strategies that we have not fully explored. Accordingly, it is not possible to estimate the potential tax obligations if we were to remit all of our funds from foreign locations to the United States.

Free Cash Flow

Table MD&A 13: Free Cash Flow

(in thousands)

For the Six Months Ended March 31, 2023 March 31, 2022
Net cash provided by operating activities $175,037 $111,859
Purchases of property and equipment and capitalized software (33,751) (22,898)
Free cash flow $141,286 $88,961

27

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires us to make estimates, judgments, and assumptions that affect the amounts reported. Actual results could differ from those estimates. The 2022 Form 10-K, as filed with the SEC on November 22, 2022, includes a summary of critical accounting policies we believe are the most important to aid in understanding our financial results. There have been no changes to those critical accounting policies that have had a material impact on our reported amounts of assets, liabilities, revenues, or expenses during the three or six months ended March 31, 2023.

Non-GAAP and Other Measures

We utilize non-GAAP measures where we believe it will assist users of our financial statements in understanding our business. The presentation of these measures is meant to complement, but not replace, other financial measures in this document. The presentation of non-GAAP numbers is not meant to be considered in isolation, nor as an alternative to revenue growth, cash flows from operating activities, net income, or earnings per share as measures of performance. These non-GAAP measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.

For the three months ended March 31, 2023, 14% of our revenue was generated outside the U.S. We believe that users of our financial statements wish to understand the performance of our foreign operations using a methodology that excludes the effect of year-over-year exchange rate fluctuations. To calculate year-over-year currency movement, we determine the current fiscal year's results for all foreign businesses using the exchange rates in the prior fiscal year.

In recent years, we have made a number of acquisitions. We believe users of our financial statements wish to evaluate the performance of our operations, excluding changes that have arisen due to businesses acquired or disposed of. We identify acquired revenue and cost of revenue by showing these results for periods for which no comparative results exist within our financial statements. We identify revenue and cost of revenue that has been disposed of in a similar manner. This information is supplemented by our calculations of organic growth. To calculate organic growth, we compare current fiscal year results excluding transactions from acquisitions or disposals, to our prior fiscal year results.

Our recent acquisitions have resulted in significant intangible assets which are amortized over their estimated useful lives. We believe users of our financial statements wish to understand the performance of the business by using a methodology that excludes the amortization of our intangible assets. Accordingly, we have calculated our operating profit, net income, and earnings per share, excluding the effect of the amortization of intangible assets. We have included the following table showing our reconciliation of these income measures to their corresponding U.S. GAAP measures.

Table MD&A 14: Non-GAAP Adjusted Results Excluding Amortization of Intangible Assets

(dollars in thousands, except per share data)

For the Three Months Ended March 31, 2023 March 31, 2022 For the Six Months Ended March 31, 2023 March 31, 2022
Operating income $62,505 $75,288 $137,282 $156,817
Add back: Amortization of intangible assets 23,650 22,856 47,168 45,261
Adjusted operating income excluding amortization of intangible assets (Non-GAAP) $86,155 $98,144 $184,450 $202,078
Adjusted operating income margin excluding amortization of intangible assets (Non-GAAP) 7.1% 8.3% 7.5% 8.7%
Net income $31,788 $50,096 $71,783 $103,426
Add back: Amortization of intangible assets, net of tax 17,446 16,884 34,806 33,414
Adjusted net income excluding amortization of intangible assets (Non-GAAP) $49,234 $66,980 $106,589 $136,840
Diluted earnings per share $0.52 $0.80 $1.17 $1.66
Add back: Effect of amortization of intangible assets on diluted earnings per share 0.28 0.27 0.57 0.53
Adjusted diluted earnings per share excluding amortization of intangible assets (Non-GAAP) $0.80 $1.07 $1.74 $2.19

28

In order to sustain our cash flows from operations, we regularly refresh our fixed assets and technology. We believe that users of our financial statements wish to understand the cash flows that directly correspond with our operations and the investments we must make in those operations using a methodology that combines operating cash flows and capital expenditures. We provide free cash flow to complement our statement of cash flows. Free cash flow shows the effects of our operations and replacement capital expenditures and excludes the cash flow effects of acquisitions, purchases of our common stock, dividend payments, and other financing transactions. We have provided a reconciliation of cash flows from operations to free cash flow in "Liquidity and Capital Resources."

To sustain our operations, our principal source of financing comes from receiving payments from our customers. We believe that users of our financial statements wish to evaluate our efficiency in converting revenue into cash receipts. Accordingly, we provide DSO, which we calculate by dividing billed and unbilled receivable balances at the end of each quarter by revenue per day for the period. Revenue per day for a quarter is determined by dividing total revenue by 91 days.

Market risk

As filed, 512 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In the normal course of business, we are exposed to financial risks such as changes in interest rates, foreign currency exchange rates, and counterparty risk. We use derivative instruments to manage selected interest rate exposures. The Company's market rate risk disclosures set forth in Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk" on the 2022 Form 10-K, as filed with the SEC on November 22, 2022, have not changed materially during the six month period ended March 31, 2023.

Controls and procedures

As filed, 1,542 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that these disclosure controls and procedures were effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 182 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There were no material changes during the six months ended March 31, 2023, to the risk factors previously disclosed in the 2022 Form 10-K, as filed with the SEC on November 22, 2022.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-01-01 to 2023-03-31$1.21bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2022-10-01 to 2023-03-31$2.46bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2023-01-01 to 2023-03-31$978.2mus-gaap:CostOfRevenue
Cost of revenue6 months2022-10-01 to 2023-03-31$1.98bnus-gaap:CostOfRevenue
Gross profit3 months2023-01-01 to 2023-03-31$228.6mus-gaap:GrossProfit
Gross profit6 months2022-10-01 to 2023-03-31$473.4mus-gaap:GrossProfit
Selling, general and administrative3 months2023-01-01 to 2023-03-31$142.4mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2022-10-01 to 2023-03-31$288.9mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2023-01-01 to 2023-03-31$62.5mus-gaap:OperatingIncomeLoss
Operating income6 months2022-10-01 to 2023-03-31$137.3mus-gaap:OperatingIncomeLoss
Income tax3 months2023-01-01 to 2023-03-31$10.5mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2022-10-01 to 2023-03-31$24.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2023-01-01 to 2023-03-31$31.8mus-gaap:NetIncomeLoss
Net income6 months2022-10-01 to 2023-03-31$71.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2023-01-01 to 2023-03-31$0.52us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2022-10-01 to 2023-03-31$1.17us-gaap:EarningsPerShareDiluted
Basic EPS3 months2023-01-01 to 2023-03-31$0.52us-gaap:EarningsPerShareBasic
Basic EPS6 months2022-10-01 to 2023-03-31$1.17us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2023-01-01 to 2023-03-3161,383,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2022-10-01 to 2023-03-3161,265,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2022-10-01 to 2023-03-31$175.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2022-10-01 to 2023-03-31$33.8mus-gaap:PaymentsToAcquireProductiveAssets
Share repurchases6 months2022-10-01 to 2023-03-31$0us-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2023-03-31$56.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-03-31$951.9mus-gaap:AssetsCurrent
Total assetsAt period end2023-03-31$3.90bnus-gaap:Assets
Current liabilitiesAt period end2023-03-31$681.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-03-31$2.30bnus-gaap:Liabilities
Long-term debtAt period end2023-03-31$1.21bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2023-03-31$84.5mus-gaap:LongTermDebtCurrent

Source: SEC EDGAR, the filing index for accession 0001032220-23-000037. Last ingested by Listed: Oct 24, 2026, 15:04 ET. Listed shows no prices and gives no investment advice.